glp-1 obesity news GLP‑1 real‑world data for obesity: A new standard for metabolic care New study reveals why patients

Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS

However, as paradigms gain momentum based on mounting evidence in their favor (e.g., the potential of managed grazing to increase the health of soils, plants, animals, and humans), new combinations of practices emerge

The active ingredients used in compounding are sourced from FDA-registered facilities, but the finished compounded product has not undergone FDA approval as a complete medication

2.Uberti, F., Morsanuto, V., Ruga, S., Galla, R., Farghali, M., Notte, F., Bozzo, C., Magnani, C., Nardone, A., & Molinari, C

Functional Characterization of 20 Allelic Variants of CYP1A2. Drug Metabolism and Pharmacokinetics, vol